Biotech · Private company
Braeburn Pharmaceuticals
Track this companyFree. Adds Braeburn Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials81 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- buprenorphinePhase 3 · Chronic Lower Back PainClinicalTrials.gov · fetched Nov 12, 2026
- CAM2038 q1w or q4w exposure to SL BPN/NXPhase 3 · Opioid Use DisorderClinicalTrials.gov · fetched Nov 12, 2026
- CAM2038 q1w or q4w new to BPN treatmentPhase 3 · Opioid Use DisorderClinicalTrials.gov · fetched Nov 12, 2026
- CAM2038 SC injectionPhase 3 · Opioid Use DisordersClinicalTrials.gov · fetched Nov 12, 2026
- Risperidone implantPhase 3 · SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
- SL BPN/NX tabsPhase 3 · Opioid Use DisordersClinicalTrials.gov · fetched Nov 12, 2026
- CAM2038Phase 2 · Opioid Use DisorderClinicalTrials.gov · fetched Nov 12, 2026
- CAM2038Phase 2 · Moderate or Severe Opioid Use DisorderClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- Acceptability and Feasibility of Extended-Release Subcutaneous Buprenorphine on a Mobile Pharmacy ClinicPHASE4 · RECRUITING · started Sep 23, 2026ClinicalTrials.gov NCT07176351 · fetched Nov 12, 2026
- Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back PainPHASE3 · COMPLETED · started Sep 1, 2016ClinicalTrials.gov NCT02946073 · fetched Nov 12, 2026
- Safety and Tolerability of Risperidone ImplantsPHASE3 · COMPLETED · started Apr 1, 2016ClinicalTrials.gov NCT02773576 · fetched Nov 12, 2026
- Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid DependencePHASE3 · COMPLETED · started Dec 1, 2015ClinicalTrials.gov NCT02651584 · fetched Nov 12, 2026
- Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use DisorderPHASE3 · COMPLETED · started Nov 1, 2015ClinicalTrials.gov NCT02672111 · fetched Nov 12, 2026
- Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane ImplantPHASE2 · COMPLETED · started Oct 1, 2015ClinicalTrials.gov NCT02658357 · fetched Nov 12, 2026
- A Multiple Dose Opioid Challenge StudyPHASE2 · COMPLETED · started Oct 1, 2015ClinicalTrials.gov NCT02611752 · fetched Nov 12, 2026
- Phase II Pharmacokinetics Study of CAM2038PHASE2 · COMPLETED · started Feb 1, 2015ClinicalTrials.gov NCT02710526 · fetched Nov 12, 2026